Recent Quotes (30 days)

You have no recent quotes
chg | %

Takeda Pharmaceutical Co Ltd news

   Watch this stock
Showing stories 1 - 10 of about 115   

Articles published

4502 5,104.00 -158.00 (-3.00%)
price chart
BRIEF-Takeda Pharmaceutical and Prosetta Biosciences enter into agreement
May 2 Takeda Pharmaceutical Co Ltd. * Prosetta biosciences, inc. And takeda pharmaceutical company limited, enter into agreement to discover and develop novel compounds for neurodegenerative diseases Source text for Eikon: Further company ...
Prosetta Biosciences, Inc. And Takeda Pharmaceutical Company Limited, Enter ...
SAN FRANCISCO, May 2, 2016 /PRNewswire/ -- Prosetta Biosciences, Inc. (the "Company," or "Prosetta"), today announced that it has entered into a Feasibility and First Right of Negotiation Agreement (the "Agreement") with Takeda Pharmaceutical ...
Progress MN: Takeda Pharmaceutical Co. Limited
That was the case for the Minnesota division of Takeda, the Japan-based pharmaceutical giant, when it found a 215,000-square-foot building in Brooklyn Park that had previously been occupied by Baxalta, a spinoff company of Baxter International.
BRIEF-Prosetta Biosciences and Takeda Pharmaceutical enter into agreement
BRIEF-Prosetta Biosciences and Takeda Pharmaceutical enter into agreement. May 2 Prosetta Biosciences Inc: * Co and Takeda Pharmaceutical Co Ltd, enter into agreement to discover and develop novel compounds for neurodegenerative diseases Source ...
Takeda and Teva Establish “Teva Takeda Yakuhin Ltd.” in Japan
JERUSALEM & OSAKA, Japan--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE and TASE:TEVA) and Takeda Pharmaceutical Company Limited (TSE:4502) announce the establishment of Teva Takeda Yakuhin Ltd. (“Teva Takeda Yakuhin”).
Teva and Takeda name pharma veteran as CEO of Japan joint venture  Reuters
Takeda and Nanotherapeutics Announce Agreement to Expand Takeda's ...
ALACHUA, Fla. & OSAKA, Japan--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (Takeda) (TOKYO: 4502) and Nanotherapeutics, Inc., announced an agreement providing Takeda with expanded commercialization and technology access ...
Takeda Pharmaceuticals U.S.A., Inc. Announces Plans to Transform Business ...
Also as part of the targeted focus, Takeda has created a General Medicine Business Unit, led by Senior Vice President Thomas Gibbs, most recently of Vanda Pharmaceuticals, to support operations and marketing of the company's medicines in the areas of ...
Pharmaceutical giant Takeda plans first US plant in Brooklyn Park
Takeda Pharmaceutical Co. Ltd., one of the world's largest and oldest drug companies, has acquired a large biotech plant in Brooklyn Park with the intention of manufacturing the recently approved digestive-tract drug Entyvio there.
Big Brooklyn Park biotech factory sold again, this time to Takeda  Minneapolis / St. Paul Business Journal
Takeda Acquires U.S. Biologics Manufacturing Facility  Business Wire (press release)
Will AstraZeneca and Takeda Pharmaceutical Survive FDA Ruling On Their Cardiac ...
The Food and Drug Administration (FDA) has issued a ruling in relation to heart failure associated with the use of DPP-4 inhibitor saxagliptin and alogliptin, drugs marketed by AstraZeneca and Takeda Pharmaceutical respectively. The FDA emphasizes for ...
Aquinnah Pharmaceuticals Receives $5 Million Investment from Takeda ...
CAMBRIDGE, Mass., Dec. 21, 2015 /PRNewswire/ -- Aquinnah Pharmaceuticals announced today that it has received a $5 Million investment from Takeda Pharmaceutical Company, Limited, in it's first private equity financing. The company has assembled a ...
Aquinnah secures $5 million private equity investment from Takeda  News-Medical.net